Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126550661 | 12655066 | 1 | I | 20150825 | 20160810 | 20160816 | 20160816 | EXP | FR-PFIZER INC-2016382555 | PFIZER | 68.00 | YR | M | Y | 0.00000 | 20160816 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126550661 | 12655066 | 1 | PS | TAHOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | N | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 126550661 | 12655066 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 1X/DAY | 21446 | 300 | MG | CAPSULE, HARD | QD | ||||||
| 126550661 | 12655066 | 3 | SS | METFORMIN HCL | METFORMIN HYDROCHLORIDE | 1 | Oral | 3 DF, 1X/DAY | 0 | 3 | DF | QD | |||||||
| 126550661 | 12655066 | 4 | SS | VALSARTAN. | VALSARTAN | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 126550661 | 12655066 | 5 | SS | ATENOLOL. | ATENOLOL | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 126550661 | 12655066 | 6 | SS | GLICLAZIDE | GLICLAZIDE | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 126550661 | 12655066 | 7 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 126550661 | 12655066 | 8 | SS | PERMIXON | SAW PALMETTO | 1 | Oral | 320 MG, 1X/DAY | 0 | 320 | MG | CAPSULE | QD | ||||||
| 126550661 | 12655066 | 9 | SS | KESTIN | EBASTINE | 1 | Oral | 1 DF, 1X/DAY | 0 | 1 | DF | QD | |||||||
| 126550661 | 12655066 | 10 | SS | LEVEMIR | INSULIN DETEMIR | 1 | Subcutaneous | 22 IU, DAILY | 0 | 22 | IU | ||||||||
| 126550661 | 12655066 | 11 | SS | DOLIPRANE | ACETAMINOPHEN | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126550661 | 12655066 | 1 | Dyslipidaemia |
| 126550661 | 12655066 | 3 | Type 2 diabetes mellitus |
| 126550661 | 12655066 | 4 | Hypertension |
| 126550661 | 12655066 | 5 | Hypertension |
| 126550661 | 12655066 | 6 | Type 2 diabetes mellitus |
| 126550661 | 12655066 | 8 | Benign prostatic hyperplasia |
| 126550661 | 12655066 | 10 | Diabetes mellitus |
| 126550661 | 12655066 | 11 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126550661 | 12655066 | HO |
| 126550661 | 12655066 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126550661 | 12655066 | Dyspnoea | |
| 126550661 | 12655066 | Interstitial lung disease | |
| 126550661 | 12655066 | Pulmonary fibrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126550661 | 12655066 | 1 | 2015 | 0 |